Comprehensive Behavioral (ComB) Model of Treatment for Trichotillomania
Status: | Recruiting |
---|---|
Conditions: | Psychiatric |
Therapuetic Areas: | Psychiatry / Psychology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 5/13/2018 |
Start Date: | May 10, 2018 |
End Date: | December 31, 2019 |
Contact: | David A.F. Haaga, Ph.D. |
Email: | dhaaga@american.edu |
Phone: | 202-885-1718 |
Randomized Controlled Trial of the Comprehensive Behavioral (ComB) Model of Treatment for Trichotillomania
This study will be the first randomized controlled trial of Comprehensive Behavior
Modification (ComB) as a treatment of trichotillomania (TTM). ComB treatment (12 weekly
sessions, following a manual developed in an earlier treatment development project) will be
compared to Minimal Attention Control among adults (N = 42) with TTM.
Modification (ComB) as a treatment of trichotillomania (TTM). ComB treatment (12 weekly
sessions, following a manual developed in an earlier treatment development project) will be
compared to Minimal Attention Control among adults (N = 42) with TTM.
Treatment based on the ComB model has been influential in the field of body-focused
repetitive behaviors (BFRB's), but there is limited empirical research on its efficacy. Our
first project (Falkenstein et al., 2016) developed a 12-session manual for ComB and a method
for evaluating therapist adherence to the model that can be used reliably and provided
encouraging (uncontrolled) data on the effects of ComB through 3-month follow-up.
The proposed project extends the earlier work in two main ways: (a) using random assignment
to ComB vs. comparison condition to test whether ComB works better than the passage of time +
demand characteristics of being in a TTM study alone; and (b) gathering initial evidence on
how ComB works.
Treatment will be conducted at two sites -- Washington, DC (American University and the
Behavior Therapy Center of Greater Washington) and Chicago (University of Chicago).
Participants in the Minimal Attention Control condition will receive ComB therapy after the
post-treatment [week 12] assessment is conducted. Uncontrolled follow-up data will be
collected through 3 (MAC condition) or 6 (immediate ComB condition) months after the end of
ComB treatment.
repetitive behaviors (BFRB's), but there is limited empirical research on its efficacy. Our
first project (Falkenstein et al., 2016) developed a 12-session manual for ComB and a method
for evaluating therapist adherence to the model that can be used reliably and provided
encouraging (uncontrolled) data on the effects of ComB through 3-month follow-up.
The proposed project extends the earlier work in two main ways: (a) using random assignment
to ComB vs. comparison condition to test whether ComB works better than the passage of time +
demand characteristics of being in a TTM study alone; and (b) gathering initial evidence on
how ComB works.
Treatment will be conducted at two sites -- Washington, DC (American University and the
Behavior Therapy Center of Greater Washington) and Chicago (University of Chicago).
Participants in the Minimal Attention Control condition will receive ComB therapy after the
post-treatment [week 12] assessment is conducted. Uncontrolled follow-up data will be
collected through 3 (MAC condition) or 6 (immediate ComB condition) months after the end of
ComB treatment.
Inclusion Criteria:
- 18 years of age or older
- diagnosed with Trichotillomania
- medication type and dosage [if any] stable for at least 3 months
Exclusion Criteria:
- active suicidality
--probable bipolar disorder
- probable psychosis
- other pressing clinical problem requiring immediate treatment
- current psychotherapy and unable/unwilling to discontinue
We found this trial at
1
site
Click here to add this to my saved trials